Imagion Biosystems Limited has lodged Appendix 3X, Final Director’s Interest Notice, with the Australian Securities Exchange.
View the Final Director’s Interest Notice.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
December 2, 2025
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2